GlobalDeal

Complix N.V.

Biotechnology · Hasselt, Belgium

complix.com

About Complix N.V.

Complix N.V. is a biotechnology company focused on the development of innovative therapeutics based on its proprietary Alphabody technology. The company specializes in the design and production of Alphabodies, which are a new class of therapeutic proteins that can be used to target and neutralize disease-causing proteins. Complix aims to address unmet medical needs in various therapeutic areas, including oncology and autoimmune diseases. The company is committed to advancing its pipeline of drug candidates through rigorous research and development, leveraging its expertise in protein engineering and biopharmaceutical development. With a strong emphasis on scientific innovation and collaboration, Complix seeks to bring transformative therapies to patients and improve health outcomes.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Therapeutics, Protein Engineering, Oncology, Autoimmune Diseases
Location
Hasselt, Belgium
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Complix N.V. in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in Belgium

All 375 Biotechnology companies in Belgium →